Siiteri, P. K. et al. The serum transport of steroid hormones. Recent Prog Horm Res 38, 457–510 (1982).
Google Scholar
Bonnet, F. et al. Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Eur J Endocrinol 161, 81–5 (2009).
Google Scholar
Ding, E. L. et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361, 1152–63 (2009).
Google Scholar
Karim, R., Hodis, H. N., Stanczyk, F. Z., Lobo, R. A. & Mack, W. J. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 93, 131–8 (2008).
Google Scholar
Li, C., Ford, E. S., Li, B., Giles, W. H. & Liu, S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 33, 1618–24 (2010).
Google Scholar
Haffner, S. M., Katz, M. S., Stern, M. P. & Dunn, J. F. Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 9, 136–43 (1989).
Google Scholar
Sutton-Tyrrell, K. et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111, 1242–9 (2005).
Google Scholar
Janne, M. & Hammond, G. L. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J Biol Chem 273, 34105–14 (1998).
Google Scholar
Selva, D. M. & Hammond, G. L. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. Endocrinology 150, 2183–9 (2009).
Google Scholar
Alvarez-Sala Walther, L. A., Millan Nunez-Cortes, J. & de Oya Otero, M. [Mediterranean diet in Spain. Legend or reality? (I). Study of 7 countries. Various elements of the Mediterranean diet: olive oil and red wine]. Rev Clin Esp 196, 548–56 (1996).
Google Scholar
Estruch, R. et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368, 1279–90 (2013).
Google Scholar
Panagiotakos, D. B. et al. The association of Mediterranean diet with lower risk of acute coronary syndromes in hypertensive subjects. Int J Cardiol 82, 141–7 (2002).
Google Scholar
Ros, E. et al. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Adv Nutr 5, 330S–6S (2014).
Google Scholar
Tektonidis, T. G., Akesson, A., Gigante, B., Wolk, A. & Larsson, S. C. A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study. Atherosclerosis 243, 93–8 (2015).
Google Scholar
Saez-Lopez, C. et al. Oleic acid increases hepatic sex hormone binding globulin production in men. Mol Nutr Food Res 58, 760–7 (2014).
Google Scholar
Opie, L. H. & Lecour, S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28, 1683–93 (2007).
Google Scholar
Renaud, S. & de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–6 (1992).
Google Scholar
St Leger, A. S., Cochrane, A. L. & Moore, F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1, 1017–20 (1979).
Google Scholar
Tresserra-Rimbau, A. et al. Moderate red wine consumption is associated with a lower prevalence of the metabolic syndrome in the PREDIMED population. Br J Nutr 113(Suppl 2), S121–30 (2015).
Google Scholar
Das, D. K. et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 25, 115–20 (1999).
Google Scholar
Mark, L., Nikfardjam, M. S., Avar, P. & Ohmacht, R. A validated HPLC method for the quantitative analysis of trans-resveratrol and trans-piceid in Hungarian wines. J Chromatogr Sci 43, 445–9 (2005).
Google Scholar
Vinson, J. A., Teufel, K. & Wu, N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156, 67–72 (2001).
Google Scholar
Gresele, P. et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 138, 1602–8 (2008).
Google Scholar
Murtaza, G. et al. Resveratrol: an active natural compounds in red wines for health. Journal of Food and Drug Analysis 21, 12 (2013).
Harikumar, K. B. & Aggarwal, B. B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020–35 (2008).
Google Scholar
Nakata, R., Takahashi, S. & Inoue, H. Recent advances in the study on resveratrol. Biol Pharm Bull 35, 273–9 (2012).
Google Scholar
Pervaiz, S. Resveratrol: from grapevines to mammalian biology. Faseb J 17, 1975–85 (2003).
Google Scholar
Wang, B. et al. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutr Res 33, 971–81 (2013).
Google Scholar
Alberdi, G. et al. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition. 29, 562–7 (2013).
Google Scholar
Cho, S. J., Jung, U. J. & Choi, M. S. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr. 108, 2166–75 (2012).
Google Scholar
Baur, J. A. & Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493–506 (2006).
Google Scholar
Bradamante, S., Barenghi, L. & Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22, 169–88 (2004).
Google Scholar
Wu, J. M. et al. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int J Mol Med 8, 3–17 (2001).
Google Scholar
Yao, R. et al. Polyphenols in alcoholic beverages activating constitutive androstane receptor CAR. Biosci Biotechnol Biochem 75, 1635–7 (2011).
Google Scholar
Handschin, C. & Meyer, U. A. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55, 649–73 (2003).
Google Scholar
Tolson, A. H. & Wang, H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev 62, 1238–49 (2010).
Google Scholar
Wortham, M., Czerwinski, M., He, L., Parkinson, A. & Wan, Y. J. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 35, 1700–10 (2007).
Google Scholar
Yang, H. & Wang, H. Signaling control of the constitutive androstane receptor (CAR). Protein Cell 5, 113–23 (2014).
Google Scholar
Honkakoski, P., Zelko, I., Sueyoshi, T. & Negishi, M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18, 5652–8 (1998).
Google Scholar
Wang, H. et al. A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278, 14146–52 (2003).
Google Scholar
Buckley, D. B. & Klaassen, C. D. Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37, 847–56 (2009).
Google Scholar
Osabe, M. et al. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab Dispos 36, 294–302 (2008).
Google Scholar
Sugatani, J. et al. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol Pharmacol 67, 845–55 (2005).
Google Scholar
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. & Negishi, M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274, 6043–6 (1999).
Google Scholar
Sugatani, J. et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232–8 (2001).
Google Scholar
Miao, J., Fang, S., Bae, Y. & Kemper, J. K. Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J Biol Chem 281, 14537–46 (2006).
Google Scholar
Reschly, E. J. & Krasowski, M. D. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab 7, 349–65 (2006).
Google Scholar
Maglich, J. M. et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278, 17277–83 (2003).
Google Scholar
Moore, L. B. et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275, 15122–7 (2000).
Google Scholar
Tzameli, I., Pissios, P., Schuetz, E. G. & Moore, D. D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20, 2951–8 (2000).
Google Scholar
Kolouchová-Hanzlíková, I., Melzoch, K., Filip, V. & Smidrkal, J. Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines. Food Chemistry 87, 151–158 (2004).
Google Scholar
Berardi, V., Ricci, F., Castelli, M., Galati, G. & Risuleo, G. Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use. J Exp Clin Cancer Res 28, 96 (2009).
Google Scholar
Ding, X. Z. & Adrian, T. E. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25(4), e71–6 (2002).
Google Scholar
Ahn, J., Cho, I., Kim, S., Kwon, D. & Ha, T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 49, 1019–28 (2008).
Google Scholar
Maier-Salamon, A., Bohmdorfer, M., Thalhammer, T., Szekeres, T. & Jaeger, W. Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog. Drug Metab Pharmacokinet 26, 364–73 (2011).
Google Scholar
Rice-Evans, C. A., Miller, N. J., Bolwell, P. G., Bramley, P. M. & Pridham, J. B. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res. 22(4), 375–83 (1995).
Google Scholar
German, J. B. & Walzem, R. L. The health benefits of wine. Annu Rev Nutr. 20, 561–93 (2000).
Google Scholar
Szewczuk, L. M., Forti, L. & Stivala, L. A. et al. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. 279, 22727–37 (2004).
Google Scholar
Sevov, M., Elfineh, L. & Cavelier, L. B. Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun. 348, 1047–54 (2006).
Google Scholar
Jiang, H. et al. Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem Res. 35(1), 152–61 (2010).
Google Scholar
Tian, Y. et al. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver. Mol Cell Biochem. 422(1–2), 75–84 (2016).
Google Scholar
Shufelt, C. et al. Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J Womens Health (Larchmt) 21, 281–4 (2012).
Google Scholar
Chow, H. H. et al. A pilot clinical study of resveratrol in postmenopausal women withhigh body mass index: effects on systemic sex steroid hormones. J Transl Med 12, 223 (2014).
Google Scholar
Selva, D. M., Hogeveen, K. N., Innis, S. M. & Hammond, G. L. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. 117(12), 3979–87 (2007).
Google Scholar
Hammond, G. L., Hogeveen, K. N., Visser, M. & Coelingh Bennink, H. J. Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells. Climacteric 11(suppl 1), 41–46 (2008).
Google Scholar
Selva, D. M. & Hammond, G. L. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J Mol Endocrinol 43, 19–27 (2009).
Google Scholar
Wallace, B.D., Redinbo, M.R. Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metab Rev. Feb;45(1):79–100 (2013).
Laaksonen, D. E. et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 27(5), 1036–1041 (2004).
Google Scholar
Bhasin, S. et al. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care. 34(11), 2464–2470 (2011).
Google Scholar
Haffner, S. M., Valdez, R. A., Morales, P. A., Hazuda, H. P. & Stern, M. P. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab. 77(1), 56–60 (1993).
Google Scholar
Lindstedt, G. et al. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes. 40(1), 123–128 (1991).
Google Scholar
Janne, M., Deol, H. K., Power, S. G., Yee, S. P. & Hammond, G. L. Human sex hormone-binding globulin gene expression in transgenic mice. Mol Endocrinol 12, 123–36 (1998).
Google Scholar
Scheer, N. et al. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J Clin Invest. 118(9), 3228–39 (2008).
Google Scholar